Disease Activity in Mitral Annular Calcification A Multimodality Study

被引:61
|
作者
Massera, Daniele [1 ]
Trivieri, Maria G. [2 ]
Andrews, Jack P. M. [3 ]
Sartori, Samantha [2 ]
Abgral, Ronan [4 ]
Chapman, Andrew R. [3 ]
Jenkins, William S. A. [3 ]
Vesey, Alex T. [3 ]
Doris, Mhairi K. [3 ]
Pawade, Tania A. [3 ]
Zheng, Kang H. [5 ]
Kizer, Jorge R. [6 ,7 ]
Newby, David E. [3 ]
Dweck, Marc R. [3 ]
机构
[1] NYU, Sch Med, Leon H Charney Div Cardiol, New York, NY USA
[2] Icahn Sch Med Mt Sinai, Dept Cardiol, New York, NY 10029 USA
[3] Univ Edinburgh, British Heart Fdn Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland
[4] Univ Hosp Brest, Dept Nucl Med, Brest, France
[5] Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands
[6] San Francisco Vet Affairs Hlth Care Syst, Cardiol Sect, San Francisco, CA USA
[7] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
基金
英国惠康基金;
关键词
disease progression; inflammation; mitral valve; positron emission tomography computed tomography; AORTIC-VALVE SCLEROSIS; INFLAMMATION; ASSOCIATION; STENOSIS; HEART; BONE; SKELETON; DENSITY; CALCIUM; ADULTS;
D O I
10.1161/CIRCIMAGING.118.008513
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Mitral annular calcification (MAC) is associated with cardiovascular events and mitral valve dysfunction. However, the underlying pathophysiology remains incompletely understood. In this prospective longitudinal study, we used a multimodality approach including positron emission tomography, computed tomography, and echocardiography to investigate the pathophysiology of MAC and assess factors associated with disease activity and progression. METHODS: A total of 104 patients (age 72 +/- 8 years, 30% women) with calcific aortic valve disease, therefore predisposed to MAC, underwent F-18-sodium fluoride (calcification activity) and F-18-Fluorodeoxyglucose (inflammation activity) positron emission tomography, computed tomography calcium scoring, and echocardiography. Sixty patients underwent repeat computed tomography and echocardiography after 2 years. RESULTS: MAC (mitral annular calcium score>0) was present in 35 (33.7%) patients who had increased F-18-fluoride (tissue-to-background ratio, 2.32 [95% CI, 1.81-3.27] versus 1.30 [1.22-1.49]; P<0.001) and F-18-Fluorodeoxyglucose activity (tissue-to-background ratio, 1.44 [1.37-1.58] versus 1.17 [1.12-1.24]; P<0.001) compared with patients without MAC. MAC activity (F-18-fluoride uptake) was closely associated with the local calcium score and F-18-Fluorodeoxyglucose uptake, as well as female sex and renal function. Similarly, MAC progression was closely associated with local factors, in particular, baseline MAC. Traditional cardiovascular risk factors and calcification activity in bone or remote atherosclerotic areas were not associated with disease activity nor progression. CONCLUSIONS: MAC is characterized by increased local calcification activity and inflammation. Baseline MAC burden was associated with disease activity and the rate of subsequent progression. This suggests a self-perpetuating cycle of calcification and inflammation that may be the target of future therapeutic interventions.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Mechanisms of mitral annular calcification
    Massera, Daniele
    Kizer, Jorge R.
    Dweck, Marc R.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2020, 30 (05) : 289 - 295
  • [2] Multimodality imaging of caseous mitral annular calcification complicated by possible systemic embolizations
    Stankowski, Kamil
    Tavernese, Annamaria
    Ancona, Francesco
    Agricola, Eustachio
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2025, 41 (01) : 173 - 175
  • [3] Severe Mitral Annular Calcification Multimodality Imaging for Therapeutic Strategies and Interventions
    Eleid, Mackram F.
    Foley, Thomas A.
    Said, Sameh M.
    Pislaru, Sorin V.
    Rihal, Charanjit S.
    JACC-CARDIOVASCULAR IMAGING, 2016, 9 (11) : 1318 - 1337
  • [4] Mitral valve surgery for mitral annular calcification
    Wehbe, Mahmoud S.
    Poeling, Jochen
    Perier, Patrick
    Doll, Nicolas
    ZEITSCHRIFT FUR HERZ THORAX UND GEFASSCHIRURGIE, 2023, : 61 - 68
  • [5] Clinical Outcomes of Mitral Valve Disease With Mitral Annular Calcification
    Fukui, Miho
    Cavalcante, Joao L.
    Ahmed, Aisha
    Bae, Richard
    Bapat, Vinayak N.
    Gossl, Mario
    Garcia, Santiago
    Enriquez-Sarano, Maurice
    Sorajja, Paul
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 174 : 107 - 113
  • [6] The Relationship Between Mitral Annular Calcification and Controlling Nutritional Status Score
    Buber, Ipek
    Adali, Mehmet Koray
    Kaya, Derya
    Kilic, Ismail Dogu
    Yilmaz, Samet
    Dursunoglu, Dursun
    BRAZILIAN JOURNAL OF CARDIOVASCULAR SURGERY, 2022, 37 (06) : 908 - 913
  • [7] Mitral annular calcification as a predictor of stroke in the multiethnic study of atherosclerosis
    Onuegbu, Afiachukwu
    Calicchio, Francesca
    Kinninger, April
    Nakanishi, Rine
    Carr, John J.
    Nasir, Khurram
    Gottesman, Rebecca
    Budoff, Matthew
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2023, 24 (09) : 680 - 688
  • [8] Bone mineral density and long-term progression of aortic valve and mitral annular calcification: The Multi-Ethnic Study of Atherosclerosis
    Massera, Daniele
    Buzkova, Petra
    Bortnick, Anna E.
    Owens, David S.
    Mao, SongShou
    Li, Dong
    De Boer, Ian H.
    Kestenbaum, Bryan R.
    Budoff, Matthew J.
    Kizer, Jorge R.
    ATHEROSCLEROSIS, 2021, 335 : 126 - 134
  • [9] Prevalence of mitral annular calcification and its association with mitral valvular disease
    Okura, Hiroyuki
    Nakada, Yasuki
    Nogi, Maki
    Ishihara, Satomi
    Okamura, Akihiko
    Okayama, Satoshi
    Watanabe, Makoto
    Kawakami, Rika
    Saito, Yoshihiko
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2021, 38 (11): : 1907 - 1912
  • [10] Mitral Annular Calcification-Related Valvular Disease: A Challenging Entity
    Museedi, Abdulrahman S.
    Le Jemtel, Thierry H.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (03)